Radnor Capital Management’s Cytosorbents Corp CTSO Stock Holding History

Radnor Capital Management’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,000	Closed	-$80K	–	198
2020 Q3	$80K	Hold	10,000	–	–	0.03%	188
2020 Q2	$100K	Hold	10,000	–	–	0.04%	176
2020 Q1	$77K	Hold	10,000	–	–	0.03%	162
2019 Q4	$39K	Hold	10,000	–	–	0.01%	185
2019 Q3	$50K	Hold	10,000	–	–	0.02%	176
2019 Q2	$66K	Hold	10,000	–	–	0.02%	181
2019 Q1	$76K	Hold	10,000	–	–	0.02%	176
2018 Q4	$81K	Hold	10,000	–	–	0.03%	168
2018 Q3	$129K	Hold	10,000	–	–	0.04%	179
2018 Q2	$114K	Hold	10,000	–	–	0.04%	172
2018 Q1	$70K	Hold	10,000	–	–	0.02%	175
2017 Q4	$65K	Buy	+10,000	New	+$63.6K	0.02%	179

Other funds holding CTSO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Radnor Capital Management's CTSO Position: Q4 2020 in Review

Radnor Capital Management sold out of Cytosorbents Corp (CTSO) in Q4 2020, closing a stake of 10,000 shares — an estimated $80K sold.

Radnor Capital Management first reported a position in CTSO in Q4 2017 and held it in 12 quarters. The position peaked at $129K in Q3 2018. 94 funds tracked by Wall St. Rank hold CTSO as of Q4 2020.

Radnor Capital Management reported no remaining Cytosorbents Corp position as of Q4 2020 after selling out during the quarter.
Radnor Capital Management sold 10,000 Cytosorbents Corp shares in Q4 2020, an estimated $80K.
Radnor Capital Management first reported a position in Cytosorbents Corp in Q4 2017 and held it in 12 quarters.
Radnor Capital Management's Cytosorbents Corp position peaked at $129K in Q3 2018.
94 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2020.

Based on Radnor Capital Management's 13F filing for Q4 2020, filed 13 Jan 2021.